Recruiting NCT03409159
Austrian Left Atrial Appendage Closure Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: LAAC.
- Who it may be relevant to
- Registry conditions: Atrial Fibrillation, Left Atrial Appendage Closure. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Austria
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
Interventions
- Device LAAC
Left atrial appendage closure
Primary outcome measures
- Number of participants with successful left atrial appendage closure, as defined by European Society of Cardiology Guidelines [Time frame: 30 days]
Secondary outcome measures (2)
- Number of participants with death, stroke or bleeding [Time frame: 5 years]
- Number of participants with procedure-related adverse events [Time frame: 30 days]
Eligibility criteria
Inclusion criteria
- Patients who received LAAC in Austria
Exclusion criteria
- Absence of informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Austria · 1 center
- Medical University of Graz — Graz
Identifiers
NCT: NCT03409159 · 29-355 ex 16/17